| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) | 
|---|
| 04/22/2014 | US8704046 Soybean cultivar WN0912893 | 
| 04/22/2014 | US8704044 Nucleic acids that encode ERS1 from maize and their uses | 
| 04/22/2014 | US8704043 Plants having increased yield-related traits and a method for making the same | 
| 04/22/2014 | US8704042 Tor-interacting proteins (TIPs) and genes therefor | 
| 04/22/2014 | US8704041 Methods and compositions for targeted polynucleotide modification | 
| 04/22/2014 | US8704040 B. braunii, race B gene for a triterpene methyltransferase enzyme and uses thereof | 
| 04/22/2014 | US8703930 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes | 
| 04/22/2014 | US8703929 Compositions comprising siRNA and plasmids | 
| 04/22/2014 | US8703928 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays | 
| 04/22/2014 | US8703916 B7-H3 and B7-H4, novel immunoregulatory molecules | 
| 04/22/2014 | US8703914 Heterologous expression of neisserial proteins | 
| 04/22/2014 | US8703908 Expression and export of angiogenesis inhibitors as immunofusins | 
| 04/22/2014 | US8703735 Antisense antiviral compounds and methods for treating a filovirus infection | 
| 04/22/2014 | US8703732 Composition for enhancing TRAIL sensitivity comprising inhibitors for expression or activity of TIP41 as a target gene of TRAIL sensitizer | 
| 04/22/2014 | US8703731 Sphingosine-bound siRNA | 
| 04/22/2014 | US8703729 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene | 
| 04/22/2014 | US8703728 Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini | 
| 04/22/2014 | US8703489 Methods and compositions for targeted single-stranded cleavage and targeted integration | 
| 04/22/2014 | US8703482 Human artificial chromosome (HAC) vector | 
| 04/22/2014 | US8703481 Episomal expression vector for metazoan cells | 
| 04/22/2014 | US8703471 System and method for the production of recombinant glycosylated proteins in a prokaryotic host | 
| 04/22/2014 | US8703469 Baculoviruses with enhanced virion production and a method for the production of baculoviruses | 
| 04/22/2014 | US8703462 Generation of random double-strand breaks in DNA using enzymes | 
| 04/22/2014 | US8703459 Catalytic domains of beta(1,4)-galactosyltransferase I having altered metal ion specificity | 
| 04/22/2014 | US8703455 Production of volatile dienes by enzymatic dehydration of light alkenols | 
| 04/22/2014 | US8703449 Bioabsorbable polymer containing 2-hydroxyacid monomers | 
| 04/22/2014 | US8703439 Point of care iodine sensor | 
| 04/22/2014 | US8703429 Composition exhibiting a von Willebrand Factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV | 
| 04/22/2014 | US8703426 Composition exhibiting a von Willebrand Factor (vWF) protease activity with the amino acid sequence AAGGILHLELLV | 
| 04/22/2014 | US8703419 Method for diagnosis/prognosis of cancers using an epigenetic marker consisting of a specific single CpG site in TTP promoter and treatment of cancers by regulating its epigenetic status | 
| 04/22/2014 | US8703418 Methods and apparatus for producing high purity X-chromosome bearing and Y-chromosome bearing populations of spermatozoa | 
| 04/22/2014 | US8703143 Antibodies of the ED-B domain of fibronectin, their construction and uses | 
| 04/22/2014 | US8703141 Method for treating Crohn's disease by administering an anti-IL-12 antibody | 
| 04/22/2014 | US8703140 Inhibition of factor B, the alternative complement pathway and methods related thereto | 
| 04/22/2014 | US8703133 Antibody variants | 
| 04/22/2014 | US8703128 Methods of modulating TGFβ signaling | 
| 04/22/2014 | CA2751655C Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) | 
| 04/22/2014 | CA2704532C Zymomonas with improved ethanol production in medium containing concentrated sugars and acetate | 
| 04/22/2014 | CA2658677C Novel bacillus thuringiensis gene with lepidopteran activity | 
| 04/22/2014 | CA2652377C Use of non-agrobacterium bacterial species for plant transformation | 
| 04/22/2014 | CA2642654C Process for preparing human g-csf | 
| 04/22/2014 | CA2622894C New esterases and their use for processes for kinetic resolution of butinolesters | 
| 04/22/2014 | CA2609234C Anti-il2 antibodies | 
| 04/22/2014 | CA2607757C Abfb-1 gene of penicillium funiculosum | 
| 04/22/2014 | CA2589937C Rhamnose promoter expression system | 
| 04/22/2014 | CA2580713C Isolated polypeptides and polynucleotides encoding same for generating plants with increased cuticlar water permeability | 
| 04/22/2014 | CA2580620C Method of detecting hepatitis b virus s antigen | 
| 04/22/2014 | CA2572015C Fc-interferon-beta fusion proteins | 
| 04/22/2014 | CA2548135C Synthetic hla binding peptide analogues and uses thereof | 
| 04/22/2014 | CA2546775C A system for plasmid maintenance comprising a cell growth inhibiting chromosomal gene and a plasmid encoding antisense sequence | 
| 04/22/2014 | CA2546287C Reduction of dermal scarring | 
| 04/22/2014 | CA2507817C Il-21 production in prokaryotic hosts | 
| 04/22/2014 | CA2507307C Increased production of secg protein in bacillus subtilis | 
| 04/22/2014 | CA2507125C Ena nucleic acid pharmaceuticals capable of modifying splicing of mrna precursors | 
| 04/22/2014 | CA2469785C Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor | 
| 04/22/2014 | CA2398998C Cd40-binding apc-activating molecules | 
| 04/22/2014 | CA2394357C Modified leukotoxin gene and protein | 
| 04/22/2014 | CA2345209C Antisense modulation of integrin .alpha.4 expression | 
| 04/22/2014 | CA2342053C Modified tobacco 5-epi-aristolochene synthases | 
| 04/19/2014 | CA2830548A1 Methods for transforming tarwi and for producing molecular farming products in transgenic tarwi seed | 
| 04/17/2014 | WO2014059381A1 Mll3 germline breast cancer biomarkers and uses thereof | 
| 04/17/2014 | WO2014059370A1 Improved high throughput system for genetic studies | 
| 04/17/2014 | WO2014059296A1 An attenuated ehec and clostridial toxins tcda and tcdb based vaccine for clostridium difficil associated disease (cdad) | 
| 04/17/2014 | WO2014059255A1 Transcription activator-like effector (tale) - lysine-specific demethylase 1 (lsd1) fusion proteins | 
| 04/17/2014 | WO2014059248A1 Mir-155 enhancement of cd8+ t cell immunity | 
| 04/17/2014 | WO2014059173A2 T cell modifying compounds and uses thereof | 
| 04/17/2014 | WO2014059155A1 Guard cell promoters and uses thereof | 
| 04/17/2014 | WO2014059154A1 Genetically encoded calcium indicators and methods of use | 
| 04/17/2014 | WO2014059089A1 Chemiluminescent aptasensors | 
| 04/17/2014 | WO2014058985A1 High-throughput assays for enzyme inhibitors and peptide inhibitors against hiv-1 and methods for using them | 
| 04/17/2014 | WO2014058881A1 Methods for treatment of alport syndrome | 
| 04/17/2014 | WO2014058721A1 FIELD-BASED qPCR MICROBIAL MONITORING | 
| 04/17/2014 | WO2014058355A1 Method for the quantitive analysis of terminal nucleotides of a g chain of human telomeric dna | 
| 04/17/2014 | WO2014058295A1 Methods for obtaining a genetically modified plant or microbe and for increasing oil yield | 
| 04/17/2014 | WO2014058254A1 Composition for estimating risk of onset of systemic lupus erythematosus, comprising primer for detecting dna copy number variation in 1q25.1(rabgap1l) location, 6p21.32 (c4) location and 10.q21.3 location | 
| 04/17/2014 | WO2014058104A1 Method for preparing transformed plant with increased syringin production, and plant prepared by same | 
| 04/17/2014 | WO2014058094A1 Novel single nucleotide variations marker for hypoxia adaptive traits | 
| 04/17/2014 | WO2014058093A1 Novel single nucleotide variations marker for white fur/hair traits | 
| 04/17/2014 | WO2014058071A1 Cyclopropanamine compound and use thereof | 
| 04/17/2014 | WO2014058025A1 Method of establishing modified host cell | 
| 04/17/2014 | WO2014057528A1 Method for detecting squamous cell carcinoma | 
| 04/17/2014 | WO2014057437A2 Method for preparing c1q recombinant protein | 
| 04/17/2014 | WO2014057432A2 Multicomponent lipid nanoparticles and processes for the preparation thereof | 
| 04/17/2014 | WO2014057315A1 A nucleotide sequence and a process thereof | 
| 04/17/2014 | WO2014057036A1 Genetically engineered yeast | 
| 04/17/2014 | WO2014056623A2 Tyrosinase inhibitors for depigmentation or hair removal | 
| 04/17/2014 | WO2014056622A1 Ex vivo method for introducing nucleic acids into cells | 
| 04/17/2014 | WO2014056422A1 hnRNP A2* PROTEIN, NUCLEIC ACID FOR CODING PROTEIN AND USE THEREOF | 
| 04/17/2014 | WO2014056414A1 Reduction stimuli-responsive gene vector system and preparation and use thereof | 
| 04/17/2014 | WO2014056199A1 Production and purification methods of polypeptide | 
| 04/17/2014 | WO2014030097A3 Solid dishwashing detergent with improved protease performance | 
| 04/17/2014 | WO2014030096A3 Genes and processes for the production of clavine-type alkaloids | 
| 04/17/2014 | WO2014029761A3 Cell-free and minimized metabolic reaction cascades for the production of chemicals | 
| 04/17/2014 | WO2014028773A3 Lignin degrading enzymes from macrophomina phaseolina and uses thereof | 
| 04/17/2014 | WO2014028461A3 Treatment and diagnosis of melanoma | 
| 04/17/2014 | WO2014022475A3 Compositions and methods for conformationally stabilizing primate immunodeficiency virus envelope glycoprotein trimers | 
| 04/17/2014 | WO2014011817A3 Genome surgery with paired, permeant endonuclease excision | 
| 04/17/2014 | WO2013110064A9 Fusion protein for enhancing immunogenicity of bacterial antigen/immunogen | 
| 04/17/2014 | WO2012122499A3 Prostate cancer cell lines, gene signatures and uses thereof | 
| 04/17/2014 | WO2012122405A3 Screening assays using stem cells and stem cell-derived neurons from mouse models of alzheimer's disease |